Cargando…
A rare case of osteonecrosis of the jaw related to imatinib
Osteonecrosis of the jaw (ONJ) is commonly described as an adverse effect of the use of bisphosphonates. A few cases of ONJ associated with tyrosine kinase inhibitors (sunitinib, imatinib) have been reported in the literature and usually they occurred in patients simultaneously treated with bisphosp...
Autores principales: | Viviano, Massimo, Rossi, Marco, Cocca, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Oral and Maxillofacial Surgeons
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410424/ https://www.ncbi.nlm.nih.gov/pubmed/28462197 http://dx.doi.org/10.5125/jkaoms.2017.43.2.120 |
Ejemplares similares
-
A case of bisphosphonate-related osteonecrosis of the jaw with a particularly unfavourable course: a case report
por: Viviano, Massimo, et al.
Publicado: (2017) -
Medication-Related Osteonecrosis of the Jaw Spontaneously Occurred in a Patient with Chronic Myelogenous Leukemia Only by Imatinib: A Report of a Rare Case
por: Okubo-Sato, Makiko, et al.
Publicado: (2021) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
por: de Sales Lima, Marco Vinícius, et al.
Publicado: (2018) -
A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants
por: Maluf, Gustavo, et al.
Publicado: (2019) -
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
por: Cassoni, Andrea, et al.
Publicado: (2016)